Clinical trial
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in…
NCT00206739 · Bernhard Nocht Institute for Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00206739 |
|---|---|
| Title | Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants |
| Official title | Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant: a Randomized, Double-blind, and Placebo-controlled Clinical Trial |
| Lead sponsor | Bernhard Nocht Institute for Tropical Medicine, Other |
| Collaborators | German Federal Ministry of Education and Research Deutscher Akademischer Austausch Dienst The Volkswagen Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria, Anemia |
| Intervention type | Drug |
| Interventions | Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg) |
| Enrollment | 1,070 |
| Start date | Jan 1, 2003 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 30, 2010 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: